WINSTON-SALEM, N.C., Oct. 30, 2026 /PRNewswire/ -- Today, Modoral Brands Inc., an operating company of Reynolds American Inc. (Reynolds American), received U.S. FDA Marketing Granted Orders for a select number of VELO nicotine pouches.

"Today's Marketing Granted Orders demonstrate the FDA's leadership in accelerating progress toward a Smokeless America," said David Waterfield, President and CEO at Reynolds American Inc. "With adult smoking rates below 10 percent for the first time in recorded history, science‑based decisions like this highlight the role that FDA‑authorized alternatives can play in driving further declines in cigarette smoking."

Reynolds American [and its] companies will continue to work with FDA as it evaluates our submissions for additional products. We are confident in the science that supports our submissions and look forward to additional authorizations. 

FDA's Marketing Granted Orders included the following flavors and strengths:

• VELO Mini Pouch 400 mg Crema 4 mg
  
  
• VELO Mini Pouch 400 mg Lime 4 mg
  
  
• VELO Mini Pouch 400 mg Orange Crema 4 mg
  
  
• VELO Mini Pouch 400 mg Passion Fruit 4 mg
  
  
• VELO Mini Pouch 2 400 mg Crema 4 mg
  
  
• VELO Mini Pouch 2 400 mg Lime 4 mg
  
  
• VELO Mini Pouch 2 400 mg Orange Crema 4 mg
  
  
• VELO Mini Pouch 2 400 mg Cinnamon 4 mg

Reynolds American's multicategory portfolio is aligned with where adult smokers are heading — away from combustible cigarettes. For those who continue to use nicotine, potentially less risky alternatives like responsibly marketed vapor and nicotine pouches expand options for the nearly 30 million Americans who still smoke and are looking to transition away from cigarettes.

At the same time, continued decline in smoking rates will depend on providing adult smokers with more innovative alternatives, as well as addressing a still-thriving illicit marketplace of vapor products, which evade regulation and are intentionally designed and marketed to youth.

Recently, Reynolds American announced a forward-looking planned commitment to invest more than $3.2 billion in support of the organization's continued evolution toward a predominantly smokeless future, building on momentum in high growth categories, like nicotine pouches – these authorizations support the organization's investment to grow manufacturing in America. The investment began in 2024 and is expected to support more than 2,000 direct and indirect jobs across Reynolds American's operations and U.S. supply network, including roles tied to recent manufacturing expansion and innovation initiatives. 

About Reynolds American Inc. Reynolds American Inc. is a wholly owned subsidiary of the global BAT Group and the U.S. parent company of R.J. Reynolds Tobacco Company, Santa Fe Natural Tobacco Company, Inc., American Snuff Company, LLC, R.J. Reynolds Vapor Company, and Modoral Brands Inc. References to "Reynolds American," "Reynolds American companies", "the group," "the company," "the organization," "we," "us," and "our" are simply for convenience and generally refer to Reynolds American Inc. and/or its subsidiaries, collectively. To learn more about Reynolds American Inc. and its operating companies, please visit www.reynoldsamerican.com.

About VELO/Modoral Brands Inc. VELO is the industry-leading global modern oral nicotine brand. VELO-branded products in the United States are designed to provide age 21+ nicotine consumers with innovative alternatives to traditional combustible and smokeless tobacco. VELO products are marketed in the United States by Modoral Brands Inc. (Modoral), an operating company of Reynolds American Inc., a member of the British American Tobacco Group. Modoral remains committed to responsibly marketing VELO products. To learn more about Modoral, visit ModoralBrands.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/velo-nicotine-pouches-receive-us-fda-marketing-authorization-302925271.html

SOURCE Reynolds American Inc.